Doximity Inc
For the period ended Mar 31, 2025. Filed May 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 20, 2025
DOCS$32.42-1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except per share data)
| As of March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $209,614 | $96,785 |
| Marketable securities | 706,050 | 666,115 |
| Accounts receivable, net of allowance for doubtful accounts of $1,937 and $1,893 as of March 31, 2025 and 2024, respectively | 128,354 | 101,332 |
| Prepaid expenses and other current assets | 44,602 | 48,709 |
| Total current assets | 1,088,620 | 912,941 |
| Property and equipment, net | 13,656 | 12,318 |
| Deferred income tax assets | 60,014 | 45,068 |
| Operating lease right-of-use assets | 8,886 | 12,332 |
| Intangible assets, net | 23,072 | 27,317 |
| Goodwill | 67,940 | 67,940 |
| Other assets | 2,121 | 1,458 |
| Total assets | $1,264,309 | $1,079,374 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $1,356 | $2,253 |
| Accrued expenses and other current liabilities | 38,405 | 43,703 |
| Deferred revenue, current | 114,285 | 99,145 |
| Operating lease liabilities, current | 2,211 | 2,149 |
| Total current liabilities | 156,257 | 147,250 |
| Deferred revenue, non-current | 280 | 211 |
| Operating lease liabilities, non-current | 10,185 | 12,397 |
| Contingent earn-out consideration liability, non-current | 5,579 | 10,895 |
| Other liabilities, non-current | 9,383 | 7,224 |
| Total liabilities | 181,684 | 177,977 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value; 100,000 shares authorized as of March 31, 2025 and 2024, respectively; zero shares issued and outstanding as of March 31, 2025 and 2024, respectively | — | — |
| Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March 31, 2025 and 2024, respectively; 188,875 and 186,562 shares issued and outstanding as of March 31, 2025 and 2024, respectively | 189 | 187 |
| Additional paid-in capital | 894,225 | 823,885 |
| Accumulated other comprehensive income (loss) | 1,323 | (2,664) |
| Retained earnings | 186,888 | 79,989 |
| Total stockholders' equity | 1,082,625 | 901,397 |
| Total liabilities and stockholders’ equity | $1,264,309 | $1,079,374 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.